« GenoSpace: A Genomics Analysis System in the Cloud | Main | Basketball Star's Career Cut Short by Diagnosis of Marfan's Syndrome »


The PACS Designer

Just think, when Memorial Sloan Kettering Cancer Center and Quest Diagnostics add the specificity ICD-10-CM to their collaboration they'll have a powerful evaluation tool that should make OncoVantage a must have solution for cancer treatment analysis.


This makes sense for Quest to focus on specialty and genomic lab testing to stay alive as Theranos is barking outside their back door with common and everyday lab tests... a very interesting company on the move. LabCorp is in the same boat as well and there's breathing room, of course, as neither company is going to disappear, but will just have to rather define their focus when Theranos grows.


The comments to this entry are closed.

Corporate Underwriters



Search Lab Soft News

  • Google


Subscribe to Lab Soft News (Email and RSS Feeds)

Your email address:

Powered by FeedBlitz

November 2019

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
Blog powered by Typepad
Member since 12/2005